Argentina vs Tajikistan: Pneumococcal conjugate second or third-dose vaccines (PCVc)
Argentina
79.0%
in 2025
Tajikistan
79.0%
in 2025
Argentina rank
121st
Tajikistan rank
121st
Pneumococcal conjugate second or third-dose vaccines (PCVc) over time
- Argentina
- Tajikistan
How they compare
Argentina currently reports 79.0% against 79.0% in Tajikistan, a difference of 0.0%.
The two have swapped places 2 times across 18 shared years of data; in 2008 it was Tajikistan ahead.
Argentina ranks 121st and Tajikistan ranks 121st of 194 countries.
Argentina has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Argentina | Tajikistan | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0.0% | 0.0% | 0.0% | — |
| 2010s | 62.6% | 0.0% | 62.6% | Argentina |
| 2020s | 77.0% | 31.3% | 45.7% | Argentina |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher pneumococcal conjugate second or third-dose vaccines (pcvc), Argentina or Tajikistan?
- Argentina, at 79.0% against 79.0% in Tajikistan as of 2025.
- What is the difference in pneumococcal conjugate second or third-dose vaccines (pcvc) between Argentina and Tajikistan?
- 0.0%, with Argentina ahead.
- How many years of comparable data are there for Argentina and Tajikistan?
- 18 years are reported by both, from 2008 to 2025.
- How do Argentina and Tajikistan rank globally for pneumococcal conjugate second or third-dose vaccines (pcvc)?
- Argentina ranks 121st and Tajikistan ranks 121st of 194 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid refreshes it automatically from the source and publishes the full history for both places.